Lilly's Obesity Pill Faces Intensifying Competition from Novo

Eli Lilly's obesity pill recorded a modest performance in its second week on the market, as competition with pharmaceutical rival Novo Nordisk intensifies.

24 Apr, 17:52 — 24 Apr, 17:52

Post Share

Sources

Showing 1 of 1 sources

ReutersVery High4d ago

Lilly's obesity pill records modest second week as battle with Novo intensifies - Reuters

Lilly's obesity pill records modest second week as battle with Novo intensifies Reuters

Read full article →

PERSPECTA

PERSPECTA

Lilly's Obesity Pill Faces Intensifying Competition from Novo

Sources

Lilly's obesity pill records modest second week as battle with Novo intensifies - Reuters

Related Stories

Health experts call for workplace measures to curb burnout

Superfoods and Mediterranean Diet: A Health Shield for Modern Life

Open Embrace Launches First Preventive Medicine Mission to Leros

Former Fauci Aide Charged in Alleged Effort to Thwart Pandemic Inquiries

PERSPECTA